What did @dickdocontiktok actually say?
In a short TikTok reply, Dr. Zimmerman told a follower they can absolutely use testosterone even with obstructive sleep apnea (OSA) and high blood pressure. He claimed testosterone "will probably help" the sleep apnea, and that blood pressure can be managed by adjusting medications alongside diet, exercise, and testosterone levels, describing these as working "synergistically." His sign-off: "Do it, baby."
That kind of breezy confidence about two serious comorbidities, delivered in a 20-second video, deserves a closer look. Both OSA and hypertension are conditions where testosterone can genuinely complicate the picture, and a flat "you absolutely can" skips over meaningful nuance that patients need before making decisions.
Does the science back this up?
Partially, but not as cleanly as this video implies. The relationship between testosterone and OSA is genuinely complicated, and the blood pressure claim is more optimistic than the evidence warrants.
On sleep apnea: the claim that testosterone will "probably help" is not well-supported. Multiple studies have found the opposite. Hoyos et al. (2012, European Journal of Endocrinology) found that testosterone therapy in men with OSA worsened apnea-hypopnea index scores compared to placebo. The mechanism is plausible: testosterone can affect upper airway muscle tone and respiratory drive in ways that worsen breathing obstruction during sleep. Some smaller studies suggest improvements in sleep quality related to mood and fatigue, but those are not the same as improving OSA itself.
On blood pressure: testosterone's relationship with BP is nuanced. Some research, including Corona et al. (2016, Journal of Sexual Medicine), suggests testosterone therapy in hypogonadal men may modestly reduce diastolic BP over time. But the claim that BP can "easily be controlled" by just titrating medications is doing a lot of work. Testosterone can raise hematocrit, increase red blood cell mass, and in some patients elevate BP. That is not a simple synergy.
What did they get wrong (or right)?
Wrong: "It'll probably help the obstructive sleep apnea." This is the most problematic claim in the video. The weight of evidence suggests testosterone therapy can worsen OSA in some patients, not improve it. The American Urological Association and Endocrine Society both recommend screening for and managing OSA before initiating TRT, partly for this reason.
Partially right: the idea that blood pressure can be managed alongside testosterone therapy is not wrong in principle. For men with well-controlled hypertension and close monitoring, TRT is not automatically off the table. Liu et al. (2018, Journal of Clinical Hypertension) noted that testosterone's effect on BP varies significantly by baseline cardiovascular status.
Wrong in tone: "Do it, baby" as a clinical sign-off for someone with two active comorbidities is reckless. Patients with both hypertension and OSA have elevated cardiovascular risk at baseline. Adding testosterone without a proper workup, hematocrit monitoring, and sleep study follow-up is not a decision that should be made based on a TikTok video.
- OSA screening before TRT is a standard recommendation, not optional.
- Hematocrit must be monitored during TRT because elevated red cell mass raises cardiovascular risk.
- Uncontrolled hypertension is a reason to pause, not rush, into hormonal therapy.
What should you actually know?
If you have both OSA and high blood pressure and you are considering testosterone therapy, you are not automatically disqualified. But you need more than a social media reply to make that call safely.
OSA should be treated first, ideally with CPAP. Interestingly, there is evidence that effective CPAP therapy can itself improve testosterone levels in men with OSA. Hanafy (2007, Journal of Sexual Medicine) found CPAP use improved sexual function and hormonal parameters without adding exogenous testosterone at all. That is worth knowing before you start injecting anything.
Blood pressure should be genuinely controlled before starting TRT, not just "manageable in theory." Your prescribing physician should be tracking your hematocrit every 3 to 6 months after starting therapy, and your BP should be on a stable regimen before adding another hormonal variable.
The "synergistic" framing in this video makes TRT sound like a rising tide that lifts all boats. That is not how it works for everyone. Individual response varies, and patients with elevated cardiovascular risk at baseline need individualized assessment, not a generic green light.